Method and kit for diagnosing myocardial infarction

Details Method and kit for diagnosing myocardial infarction Method and kit for diagnosing myocardial infarction

2006-10-24

2006-10-24

Weber, Jon (Department: 1653)

Chemistry: analytical and immunological testing

Measurement of electrical or magnetic property or thermal...

Of an ionized gas

C530S300000

Reexamination Certificate

active

07125726

ABSTRACT:
The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer.

REFERENCES:
patent: 5062935 (1991-11-01), Schlag et al.
patent: 5538897 (1996-07-01), Yates, III et al.
patent: 5817768 (1998-10-01), Grieninger et al.
patent: 5827659 (1998-10-01), Patterson
patent: 6020208 (2000-02-01), Hutchens et al.
patent: 6675104 (2004-01-01), Paulse et al.
patent: 2004/0121306 (2004-06-01), Kupchak et al.
patent: WO90/14148 (1990-11-01), None
patent: WO93/24834 (1993-12-01), None
patent: WO96/14580 (1996-05-01), None
patent: WO96/36986 (1996-11-01), None
patent: WO98/07036 (1998-02-01), None
patent: WO99/42119 (1999-08-01), None
patent: WO00/09562 (2000-02-01), None
patent: WO00/49410 (2000-08-01), None
patent: WO01/05422 (2001-01-01), None
patent: WO01/75454 (2001-10-01), None
Stark, M. et al. Peptide repertoire of human cerebrospinal fluid: novel proteolytic fragments of neuroendocrine proteins. Journal of Chromatography B, 754: 357-367 (2001).
R. Richter et al, “Composition of the peptide fraction in human blood plasma: database of circulating human peptides”, Journal of Chromatography B, 726:25-35 (1999).
M. Takahashi et al, “Rapid and sensitive immunoassay for the measurement of serum S100B using isoform-specific monoclonal antibody”, Clinical Chemistry, 45(8):1307-1311 (1999).
J. Sobel et al, “Antipeptide monoclonal antibodies to defined fibrinogen Aalpha chain regions: anti-Aalpha 487-498, a structural probe for fibrinogenolysis”, Blood, 91(5):1590-1598 (Mar. 1998).
J. Scharfstein et al, “Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction”, Am J Cardiol, 78:503-510 (1996).
Database Entrez-Protein Online!. “Fibrinogen Alpha”, National Center for Biotechnology Information (NCBI), Jun. 15, 2000, disclosed FPA sequence: aa 20-35, retrieved from www.ncbi.nim,nih.gov.

Affiliated with

Also associated with

Rating

Method and kit for diagnosing myocardial infarction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and kit for diagnosing myocardial infarction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and kit for diagnosing myocardial infarction will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3651616